Time: November 14th, 9:00 am – 10:00 am Finnish time
Venue: Online, Microsoft Teams

In a world where technology continues to shape and transform healthcare, Hong Kong stands as a key player at the forefront of healthtech and e-health innovations. As a gateway to the Asia-Pacific region, Hong Kong offers unique opportunities for Finnish and European businesses aiming to make strides in these fields. Join us to explore the latest trends, opportunities, and insights in healthtech and e-health within Hong Kong’s dynamic market.

The upcoming Hong Kong Hour, organized by the Finland-Hong Kong Business Association and the Hong Kong Trade Development Council, will delve into these themes with insights from our expert speakers, who bring a wealth of experience and knowledge in connecting Finnish and European businesses to healthtech opportunities in Hong Kong.

Program

9:00 – Opening Remarks
Pertti Jalasvirta, Vice-Chair of the Finland-Hong Kong Business Association

9:00 – 9:25 – Healthtech Trends and Opportunities in Hong Kong
LEUNG Chuen-Yan, Partner (Healthcare Investments) at Value Partners

9:25 – 9:35 – Company Case: Optomed’s Journey in Hong Kong
Laura Piila, Vice President, Devices at Optomed

9:35 – 9:45 – Hong Kong Trade Development Council’s e-health resources and events
Anastasiia Derbeneva, Senior Project Manager at HKTDC

9:45 – 10:00 Q&A and Discussion

Speaker Bios

LEUNG Chuen-Yan
LEUNG Chuen-Yan is a healthcare investor and Partner (Healthcare Investments) at Value Partners, a leading asset management firm in Hong Kong. He is also the co-founder of Silver Dart Capital, a healthcare-focused investment firm based in Hong Kong, and serves as the Vice Chairman of the Hong Kong Biotechnology Organization (HKBIO), where he plays a pivotal role in promoting biotech innovation across the region. Previously, Chuen-Yan was a private equity vice president at EQT, a top-three private equity firm globally, and Lead Scientist at Procella Therapeutics, a stem cell start-up based in Stockholm. Chuen-Yan holds a PhD in Developmental Biology and Stem Cells from the University of Cambridge and conducted postdoctoral research in stem cell biology at the Karolinska Institute.

Laura Piila
Laura Piila leads Optomed’s Devices Business with 15 years of experience in global HealthTech. Optomed is the leading solution provider for AI-integrated handheld retinal imaging. The company operates globally in medtech, with a subsidiary in China and active sales operations in Asia for over 10 years.

Photo by Florian Wehde on Unsplash